Research Article

Lowly Expressed Ribosomal Protein S19 in the Feces of Patients with Colorectal Cancer

Figure 3

The Kaplan-Meier overall survival curves in patients with colorectal cancer according to fecal RPS19. The relative mRNA levels of RPS19 in the feces are stratified into two groups: RPS19 (<2.76 × 10−5) and RPS19+ (≥2.76 × 10−5). The six-year overall survival rate of the RPS19+ group ( 𝑛 = 6 2 ) is better than that of the RPS19 group ( 𝑃 = 0 . 0 0 8 , log-rank test).
394545.fig.003